Compounds > vx 497
Page last updated: 2024-09-04

vx 497 and quisinostat

vx 497 has been researched along with quisinostat in 1 studies

Compound Research Comparison

Studies
(vx 497)		Trials
(vx 497)		Recent Studies (post-2010)
(vx 497)		Studies
(quisinostat)		Trials
(quisinostat)		Recent Studies (post-2010) (quisinostat)
253771363

Protein Interaction Comparison

ProteinTaxonomyvx 497 (IC50)quisinostat (IC50)
Histone deacetylase 8Schistosoma mansoni0.3034
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoformHomo sapiens (human)0.039
Histone deacetylase 3Homo sapiens (human)0.0039
Cytochrome P450 3A4Homo sapiens (human)0.0001
Cytochrome P450 2D6Homo sapiens (human)0.0001
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoformHomo sapiens (human)0.019
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoformHomo sapiens (human)0.054
Histone deacetylase 4Homo sapiens (human)0.0026
Histone deacetylase 1Homo sapiens (human)0.0009
Histone deacetylase 7Homo sapiens (human)0.0424
Histone deacetylase 2Homo sapiens (human)0.0018
Polyamine deacetylase HDAC10Homo sapiens (human)0.0082
Histone deacetylase 11 Homo sapiens (human)0.0004
Histone deacetylase 8Homo sapiens (human)0.078
Histone deacetylase 6Homo sapiens (human)0.0664
Histone deacetylase 9Homo sapiens (human)0.0151
Histone deacetylase 5Homo sapiens (human)0.0049
Nuclear receptor corepressor 2Homo sapiens (human)0.0049

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M1

Other Studies

1 other study(ies) available for vx 497 and quisinostat

ArticleYear
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
    Disease models & mechanisms, 2023, 03-01, Volume: 16, Issue:3

    Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries

2023